Market Takeaways From Spine Startups at MNVC Competitive Landscape Market Drivers The 20th annual MNVC featured several startups working on innovative solutions to challenges in the spine market. Sep 30, 2022
Economy Challenges Orthopedic Funding and Acquisitions Investments The Numbers Economic pressure in the wake of the COVID-19 pandemic is disrupting orthopedic funding, IPOs and acquisitions. Sep 26, 2022
Mid-Tier Spine Player Profiles: ATEC, SeaSpine and ZimVie Company Revenue The Numbers In this edition of our mid-tier player profiles, we focus on three spine players in the top ten that are taking or losing market share. Sep 19, 2022
MicroPort Orthopedics Gets Market Access Boon from VBP Company Revenue The Numbers The company's 1H22 revenue declined in the low single digits due to currency pressures but it expanded market access by hundreds of hospitals. Sep 06, 2022
LimaCorporate Rides Strong Rebounds in Europe and U.S. Company Revenue The Numbers The company grew in the mid-teens for 2Q22, driven by strong COVID recoveries in most European countries along with the U.S. Sep 01, 2022
Narrowly Focused Companies Generating Significant Growth Chart of the Month The Numbers Our chart of the month for September examines five focused companies growing at many multiples of their respective markets. Aug 29, 2022
Medtronic Gains Offset by China VBP and Biologics Company Revenue The Numbers Despite share gains in its U.S. core spine products, Medtronic declined in the mid-single digits due to VBP in China and biologics declines. Aug 24, 2022
Orthopedic Companies Report Choppy Second Quarter of 2022 Market Analysis The Numbers We estimate orthopedic sales were essentially flat against the prior year as the market faced difficult comparisons and macro headwinds. Aug 24, 2022
Medartis Revises 2022 Outlook Based on Headwinds Company Revenue The Numbers The company grew in the high teens for 1H22 but lowered its full-year guidance due to OR staffing headwinds and slower U.S. growth. Aug 18, 2022
Amplitude Surgical Growth Bolstered by Novastep Line Company Revenue The Numbers The company grew in the high single digits for its fiscal year 2022, driven in part by gains in its Novastep foot and ankle business. Aug 18, 2022